Konsta Teppo
Overview
Explore the profile of Konsta Teppo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siponen R, Hartikainen J, Virrankorpi J, Lappalainen A, Teppo K, Halminen O, et al.
Scand Cardiovasc J
. 2025 Feb;
59(1):2467735.
PMID: 39951324
Background: Patients with atrial fibrillation (AF) are often treated with antiarrhythmic drugs (AADs) to maintain sinus rhythm and with heart rate-lowering drugs to achieve the optimal rate control. In this...
2.
Vanhanen M, Jaakkola J, Airaksinen J, Halminen O, Putaala J, Mustonen P, et al.
Gen Hosp Psychiatry
. 2025 Feb;
93:116-121.
PMID: 39946954
Objective: Patients with alcohol use disorders (AUD) often receive inferior care for somatic comorbidities. Our objective was to explore whether AUDs influence oral anticoagulant (OAC) initiation for stroke prevention among...
3.
Langen V, Winsten A, Airaksinen K, Teppo K
Ann Med
. 2025 Jan;
57(1):2457522.
PMID: 39862317
Background: Several randomized controlled trials (RCTs) have investigated the benefits of atrial fibrillation (AF) screening. However, since none have shown a significant reduction in stroke rates, the impact of screening...
4.
Airaksinen K, Langen V, Teppo K, Lip G
Eur J Clin Invest
. 2025 Jan;
55(4):e14390.
PMID: 39835416
No abstract available.
5.
Teppo K, Airaksinen K, Halminen O, Jaakkola J, Haukka J, Kouki E, et al.
JACC Clin Electrophysiol
. 2024 Dec;
PMID: 39708034
Background: Atrial fibrillation (AF) is a major risk factor for ischemic stroke (IS), but whether the magnitude of this risk has changed over time is unknown. Objectives: This study sought...
6.
Airaksinen K, Paana T, Vasankari T, Salonen S, Tuominen T, Linko-Parvinen A, et al.
Open Heart
. 2024 Nov;
11(2).
PMID: 39551608
Objectives: Elevations of cardiac troponin T (cTnT) levels are common after strenuous exercise. We assessed whether the composition of cTnT release after marathon race differs from that of acute myocardial...
7.
Lappalainen A, Hartikainen J, Teppo K, Halminen O, Aro A, Siponen R, et al.
Int J Cardiol Heart Vasc
. 2024 Nov;
55:101541.
PMID: 39507295
Background: Catheter ablation is a well-established treatment to prevent atrial fibrillation (AF) and atrial flutter (AFL) recurrences and to relieve symptoms, whereas pacemaker implantation and atrioventricular node (AVN) ablation is...
8.
Airaksinen J, Tuominen T, Paana T, Hellman T, Vasankari T, Salonen S, et al.
Eur Heart J Acute Cardiovasc Care
. 2024 Oct;
13(11):782-788.
PMID: 39422200
Aims: Cardiac troponin levels are elevated in Takotsubo syndrome (TTS) with significant overlap to acute myocardial infarction (MI). Long and intact cardiac troponin T (cTnT) forms are typical for MI....
9.
Salmela B, Jaakkola J, Kalatsova K, Inkovaara J, Aro A, Teppo K, et al.
Europace
. 2024 Oct;
26(10).
PMID: 39383252
Aims: Atrial fibrillation (AF) patients frequently require active rhythm control therapy to maintain sinus rhythm and reduce symptom burden. Our study assessed whether antiarrhythmic therapies (AATs) are used disproportionately between...
10.
Teppo K, Karlsson E, Kiviniemi T, Halminen O, Lehtonen O, Kouki E, et al.
Atherosclerosis
. 2024 Sep;
399:118590.
PMID: 39299822
Background And Aims: We examined temporal trends and age-related differences in the prevalence of vascular diseases and in their association with ischemic stroke (IS) risk in patients with atrial fibrillation...